Sonkin, D., Thomas, A. & Teicher, B. A. Cancer treatments: Past, present, and future. Cancer Genet. 286–287, 18–24. https://doi.org/10.1016/j.cancergen.2024.06.002 (2024).Article
CAS
PubMed
Google Scholar
Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12–49. https://doi.org/10.3322/caac.21820 (2024).Article
PubMed
Google Scholar
Xia, C. et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin. Med. J. 135, 584–590. https://doi.org/10.1097/cm9.0000000000002108 (2022).Article
PubMed
PubMed Central
Google Scholar
Britt, K. L., Cuzick, J. & Phillips, K. A. Key steps for effective breast cancer prevention. Nat. Rev. Cancer 20, 417–436. https://doi.org/10.1038/s41568-020-0266-x (2020).Article
CAS
PubMed
Google Scholar
Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7–33. https://doi.org/10.3322/caac.21708 (2022).Article
PubMed
Google Scholar
Lei, X. et al. Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy. Cancer Lett. 470, 126–133. https://doi.org/10.1016/j.canlet.2019.11.009 (2020).Article
CAS
PubMed
Google Scholar
Dieci, M. V., Miglietta, F. & Guarneri, V. Immune infiltrates in breast cancer: Recent updates and clinical implications. Cells https://doi.org/10.3390/cells10020223 (2021).Article
PubMed
PubMed Central
Google Scholar
Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711–723 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Robert, C. et al. Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma. J. Clin. Oncol. 36, 1668–1674 (2018).Article
CAS
PubMed
Google Scholar
Wang, J. et al. Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: A Bayesian network analysis. EBioMedicine 47, 78–88 (2019).Article
PubMed
PubMed Central
Google Scholar
Vonderheide, R. H., Domchek, S. M. & Clark, A. S. Immunotherapy for breast cancer: What are we missing?. Clin. Cancer Res. 23, 2640–2646 (2017).Article
PubMed
PubMed Central
Google Scholar
Emens, L. A. et al. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer: biomarker evaluation of the IMpassion130 study. J. Natl. Cancer Inst. 113, 1005–1016. https://doi.org/10.1093/jnci/djab004 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Loi, S. et al. Tumor-infiltrating lymphocytes and prognosis: A pooled individual patient analysis of early-stage triple-negative breast cancers. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 37, 559–569. https://doi.org/10.1200/jco.18.01010 (2019).Article
CAS
Google Scholar
Kwapisz, D. Pembrolizumab and atezolizumab in triple-negative breast cancer. Cancer Immunol Immunother 70, 607–617. https://doi.org/10.1007/s00262-020-02736-z (2021).Article
CAS
PubMed
Google Scholar
Latif, F. et al. Atezolizumab and pembrolizumab in triple-negative breast cancer: A meta-analysis. Exp. Rev. Anticancer Therapy 22, 229–235. https://doi.org/10.1080/14737140.2022.2023011 (2022).Article
CAS
Google Scholar
Ruffell, B. et al. Leukocyte composition of human breast cancer. Proc. Natl. Acad. Sci. USA 109, 2796–2801. https://doi.org/10.1073/pnas.1104303108 (2012).Article
ADS
PubMed
Google Scholar
König, L. et al. Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer. BMC Cancer 19, 120. https://doi.org/10.1186/s12885-019-5320-2 (2019).Article
PubMed
PubMed Central
Google Scholar
Savas, P. et al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat. Med. 24, 986–993. https://doi.org/10.1038/s41591-018-0078-7 (2018).Article
CAS
PubMed
Google Scholar
Byrne, A. et al. Tissue-resident memory T cells in breast cancer control and immunotherapy responses. Nat. Rev. Clin. Oncol. 17, 341–348. https://doi.org/10.1038/s41571-020-0333-y (2020).Article
PubMed
Google Scholar
Zhu, Z., Jiang, L. & Ding, X. Advancing breast cancer heterogeneity analysis: insights from genomics, transcriptomics and proteomics at bulk and single-cell levels. Cancers https://doi.org/10.3390/cancers15164164 (2023).Article
PubMed
PubMed Central
Google Scholar
Yu, J., Guo, Z. & Wang, L. Progress and challenges of immunotherapy predictive biomarkers for triple negative breast cancer in the era of single-cell multi-omics. Life (Basel) https://doi.org/10.3390/life13051189 (2023).Article
PubMed
PubMed Central
Google Scholar
Nolan, E., Lindeman, G. J. & Visvader, J. E. Deciphering breast cancer: from biology to the clinic. Cell 186, 1708–1728. https://doi.org/10.1016/j.cell.2023.01.040 (2023).Article
CAS
PubMed
Google Scholar
Wang, Y. et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 512, 155–160 (2014).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Chung, W. et al. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat. Commun. 8, 15081 (2017).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Kim, J. J., Liang, W., Kang, C.-C., Pegram, M. D. & Herr, A. E. Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer. Plos one 16, e0254783 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Gerlinger, M. & Swanton, C. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br. J. Cancer 103, 1139–1143 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Satam, H. et al. Next-generation sequencing technology: Current trends and advancements. Biology (Basel) https://doi.org/10.3390/biology12070997 (2023).Article
PubMed
Google Scholar
Shiovitz, S. & Korde, L. A. Genetics of breast cancer: A topic in evolution. Ann. Oncol. 26, 1291–1299 (2015).Article
CAS
PubMed
PubMed Central
Google Scholar
Griseri, P. & Pagès, G. Regulation of the mRNA half-life in breast cancer. World J. Clin. Oncol. 5, 323 (2014).Article
PubMed
PubMed Central
Google Scholar
Liu, H. & Weng, J. A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma. Gene https://doi.org/10.1016/j.gene.2022.146325 (2022).Article
PubMed
PubMed Central
Google Scholar
Liu, H. & Tao, T. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front. Oncol. https://doi.org/10.3389/fonc.2022.952290 (2022).Article
PubMed
PubMed Central
Google Scholar
Liu, H. Pan-cancer profiles of the cuproptosis gene set. Am. J. Cancer Res. 12, 4074–4081 (2022).CAS
PubMed
PubMed Central
Google Scholar
Liu, H. Pan-cancer profiles of the cuproptosis gene set. Res. Square https://doi.org/10.21203/rs.3.rs-1716214/v1 (2022).Article
Google Scholar
Li, Y. & Liu, H. Clinical powers of aminoacyl tRNA synthetase complex interacting multifunctional protein 1 (AIMP1) for head-neck squamous cell carcinoma. Cancer Biomark. Sect. A Dis. Mark. https://doi.org/10.3233/cbm-210340 (2022).Article
Google Scholar
Li, Y., Liu, H. & Han, Y. Potential Roles of Cornichon Family AMPA Receptor Auxiliary Protein 4 (CNIH4) in Head and Neck Squamous Cell Carcinoma. Research Square (2021).Liu, H. & Tang, T. MAPK signaling pathway-based glioma subtypes, machine-learning risk model, and key hub proteins identification. Sci. Rep. 13, 19055. https://doi.org/10.1038/s41598-023-45774-0 (2023).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Liu, H. & Tang, T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 278–279, 91–103. https://doi.org/10.1016/j.cancergen.2023.10.001 (2023).Article
CAS
PubMed
Google Scholar
Liu, H. & Tang, T. A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value. Am. J. Transl. Res. 15, 2140–2155 (2023).CAS
PubMed
PubMed Central
Google Scholar
Liu, H. & Tang, T. Pan-cancer genetic analysis of disulfidptosis-related gene set. bioRxiv, 2023.2002. 2025.529997 (2023).Hong, M. et al. RNA sequencing: New technologies and applications in cancer research. J. Hematol. Oncol. 13, 166. https://doi.org/10.1186/s13045-020-01005-x (2020).Article
PubMed
PubMed Central
Google Scholar
Li, X. & Wang, C. Y. From bulk, single-cell to spatial RNA sequencing. Int. J. Oral Sci. 13, 36. https://doi.org/10.1038/s41368-021-00146-0 (2021).Article
ADS
PubMed
PubMed Central
Google Scholar
Puram, S. V. et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171, 1611-1624.e1624. https://doi.org/10.1016/j.cell.2017.10.044 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Lambrechts, D. et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat. Med. 24, 1277–1289. https://doi.org/10.1038/s41591-018-0096-5 (2018).Article
CAS
PubMed
Google Scholar
Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293-1308.e1236. https://doi.org/10.1016/j.cell.2018.05.060 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Kim, C. et al. Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell 173, 879-893.e813. https://doi.org/10.1016/j.cell.2018.03.041 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Ali, H. R. et al. Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer. Nat. Cancer 1, 163–175. https://doi.org/10.1038/s43018-020-0026-6 (2020).Article
CAS
PubMed
Google Scholar
Wagner, J. et al. A single-cell atlas of the tumor and immune ecosystem of human breast cancer. Cell 177, 1330–1345. https://doi.org/10.1016/j.cell.2019.03.005 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Liu, S. Q. et al. Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer. J. Hematol. Oncol. 15, 19. https://doi.org/10.1186/s13045-022-01236-0 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
McRitchie, B. R. & Akkaya, B. Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment. Front. Immunol. 13, 940052. https://doi.org/10.3389/fimmu.2022.940052 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Han, Y. et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucl. Acids Res. 51, D1425-d1431. https://doi.org/10.1093/nar/gkac959 (2023).Article
PubMed
Google Scholar
Wang, C. et al. Integrative analyses of single-cell transcriptome and regulome using MAESTRO. Genome Biol. 21, 198. https://doi.org/10.1186/s13059-020-02116-x (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888-1902.e1821. https://doi.org/10.1016/j.cell.2019.05.031 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Xu, C. & Su, Z. Identification of cell types from single-cell transcriptomes using a novel clustering method. Bioinformatics 31, 1974–1980. https://doi.org/10.1093/bioinformatics/btv088 (2015).Article
CAS
PubMed
PubMed Central
Google Scholar
Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. https://doi.org/10.1038/nbt.4314 (2018).Article
PubMed
Google Scholar
Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334–1347. https://doi.org/10.1038/s41588-021-00911-1 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Qian, J. et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res. 30, 745–762. https://doi.org/10.1038/s41422-020-0355-0 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442–459. https://doi.org/10.1016/j.cell.2020.03.048 (2020).Article
CAS
PubMed
Google Scholar
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420. https://doi.org/10.1038/nbt.4096 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38–44 (2019).Article
CAS
Google Scholar
Monti, S., Tamayo, P., Mesirov, J. & Golub, T. Consensus clustering: A resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 52, 91–118 (2003).Article
Google Scholar
Liu, H. Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma. Cancer Genet. 274–275, 21–25. https://doi.org/10.1016/j.cancergen.2023.03.002 (2023).Article
CAS
PubMed
Google Scholar
Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500–501. https://doi.org/10.1038/ng0506-500 (2006).Article
CAS
PubMed
Google Scholar
Li, T. et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77, e108–e110. https://doi.org/10.1158/0008-5472.Can-17-0307 (2017).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Aran, D., Hu, Z. & Butte, A. J. xCell: Digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220. https://doi.org/10.1186/s13059-017-1349-1 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M. & Alizadeh, A. A. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol. Biol. (Clifton, N.J.) 1711, 243–259. https://doi.org/10.1007/978-1-4939-7493-1_12 (2018).Article
CAS
Google Scholar
Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218. https://doi.org/10.1186/s13059-016-1070-5 (2016).Article
CAS
PubMed
PubMed Central
Google Scholar
Finotello, F. et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 11, 34. https://doi.org/10.1186/s13073-019-0638-6 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Racle, J. & Gfeller, D. EPIC: A tool to estimate the proportions of different cell types from bulk gene expression data. Methods Mol. Biol. (Clifton, N.J.) 2120, 233–248. https://doi.org/10.1007/978-1-0716-0327-7_17 (2020).Article
CAS
Google Scholar
Fu, J. et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 12, 21. https://doi.org/10.1186/s13073-020-0721-z (2020).Article
PubMed
PubMed Central
Google Scholar
Tibshirani, R. The lasso method for variable selection in the Cox model. Stat. Med. 16, 385–395. https://doi.org/10.1002/(sici)1097-0258(19970228)16:4%3c385::aid-sim380%3e3.0.co;2-3 (1997).Article
CAS
PubMed
Google Scholar
Chin, S. F. et al. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol. 8, R215. https://doi.org/10.1186/gb-2007-8-10-r215 (2007).Article
CAS
PubMed
PubMed Central
Google Scholar
Lin, C. Y. et al. Hubba: Hub objects analyzer–a framework of interactome hubs identification for network biology. Nucl. Acids Res. 36, W438-443. https://doi.org/10.1093/nar/gkn257 (2008).Article
CAS
PubMed
PubMed Central
Google Scholar
Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504. https://doi.org/10.1101/gr.1239303 (2003).Article
CAS
PubMed
PubMed Central
Google Scholar
Ståhl, P. L. et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science 353, 78–82. https://doi.org/10.1126/science.aaf2403 (2016).Article
ADS
CAS
PubMed
Google Scholar
Fan, Z., Chen, R. & Chen, X. SpatialDB: A database for spatially resolved transcriptomes. Nucl. Acids Res. 48, D233-d237. https://doi.org/10.1093/nar/gkz934 (2020).Article
CAS
PubMed
Google Scholar
Zeng, X. et al. Molecular subtyping and immune score system by a novel pyroptosis-based gene signature precisely predict immune infiltrating, survival and response to immune-checkpoint blockade in breast cancer. Cancer Genet. 276–277, 60–69. https://doi.org/10.1016/j.cancergen.2023.07.007 (2023).Article
CAS
PubMed
Google Scholar
Li, W., Wu, H. & Xu, J. Construction of a genomic instability-derived predictive prognostic signature for non-small cell lung cancer patients. Cancer Genet. 278–279, 24–37. https://doi.org/10.1016/j.cancergen.2023.07.008 (2023).Article
CAS
PubMed
Google Scholar
Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucl. Acids Res. 28, 27–30. https://doi.org/10.1093/nar/28.1.27 (2000).Article
CAS
PubMed
PubMed Central
Google Scholar
Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. Publ. Soc. 28, 1947–1951. https://doi.org/10.1002/pro.3715 (2019).Article
CAS
Google Scholar
Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucl. Acids Res. 51, D587-d592. https://doi.org/10.1093/nar/gkac963 (2023).Article
CAS
PubMed
Google Scholar
Eerola, A.-K., Soini, Y. & Pääkkö, P. A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin. Cancer Res. 6, 1875–1881 (2000).CAS
PubMed
Google Scholar
Rye, I. H. et al. Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression. Mol. Oncol. 16, 88–103 (2022).Article
CAS
PubMed
Google Scholar
Liu, H. & Weng, J. A pan-cancer bioinformatic analysis of RAD51 regarding the values for diagnosis, prognosis, and therapeutic prediction. Front. Oncol. https://doi.org/10.3389/fonc.2022.858756 (2022).Article
PubMed
PubMed Central
Google Scholar
Liu, H. & Tang, T. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front. Oncol. 12, 952290. https://doi.org/10.3389/fonc.2022.952290 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Liu, H. & Li, Y. Potential roles of cornichon family AMPA receptor auxiliary protein 4 (CNIH4) in head and neck squamous cell carcinoma. Cancer Biomark. Sect. A Dis. Mark. https://doi.org/10.3233/cbm-220143 (2022).Article
Google Scholar
Liu, H., Dilger, J. P. & Lin, J. A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers. Pharmacol. Ther. https://doi.org/10.1016/j.pharmthera.2022.108302 (2022).Article
PubMed
Google Scholar
Zheng, S. et al. CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration. Int. Immunopharmacol. 129, 111625. https://doi.org/10.1016/j.intimp.2024.111625 (2024).Article
CAS
PubMed
Google Scholar
Xiao, G. et al. Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer. Oncol. Res. 30, 35–51 (2022).Article
PubMed
PubMed Central
Google Scholar
Aureli, A. et al. Breast cancer is associated with increased HLA-DRB1*11:01 and HLA-DRB1*10:01 allele frequency in a population of patients from central Italy. Immunol. Invest. 49, 489–497. https://doi.org/10.1080/08820139.2020.1737539 (2020).Article
CAS
PubMed
Google Scholar
Huang, R. et al. Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer. Front. Immunol. 14, 1251643. https://doi.org/10.3389/fimmu.2023.1251643 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Wang, Y. et al. GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer. BMC Cancer 23, 925. https://doi.org/10.1186/s12885-023-11308-0 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Liu, X., Cui, Q. & Qin, N. Low expression of KLRB1 predicts poor survival outcomes and is associated with immune infiltration in breast cancer. Transl. Cancer Res. 13, 1225–1240 (2024).Article
PubMed
PubMed Central
Google Scholar
He, J. R. et al. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients. Aging 15, 13265–13286 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Wu, C., Zhong, R., Sun, X. & Shi, J. PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapy. Front. Genet. 13, 1071270. https://doi.org/10.3389/fgene.2022.1071270 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Engelhard, V. et al. B cells and cancer. Cancer Cell 39, 1293–1296. https://doi.org/10.1016/j.ccell.2021.09.007 (2021).Article
CAS
PubMed
Google Scholar
Overgaard, N. H., Jung, J. W., Steptoe, R. J. & Wells, J. W. CD4+/CD8+ double-positive T cells: More than just a developmental stage?. J. Leukocyte Biol. 97, 31–38. https://doi.org/10.1189/jlb.1RU0814-382 (2015).Article
CAS
PubMed
Google Scholar
van der Leun, A. M., Thommen, D. S. & Schumacher, T. N. CD8(+) T cell states in human cancer: Insights from single-cell analysis. Nat. Rev. Cancer 20, 218–232. https://doi.org/10.1038/s41568-019-0235-4 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Farhood, B., Najafi, M. & Mortezaee, K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: A review. J. Cell Physiol. 234, 8509–8521. https://doi.org/10.1002/jcp.27782 (2019).Article
CAS
PubMed
Google Scholar
Mehla, K. & Singh, P. K. Metabolic regulation of macrophage polarization in cancer. Trends Cancer 5, 822–834. https://doi.org/10.1016/j.trecan.2019.10.007 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Chen, Y. et al. Type I collagen deletion in αSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell 39, 548-565.e546. https://doi.org/10.1016/j.ccell.2021.02.007 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Golby, S. J., Chinyama, C. & Spencer, J. Proliferation of T-cell subsets that contact tumour cells in colorectal cancer. Clin. Exp. Immunol. 127, 85–91. https://doi.org/10.1046/j.1365-2249.2002.01730.x (2002).Article
CAS
PubMed
PubMed Central
Google Scholar
Dolina, J. S., Van Braeckel-Budimir, N., Thomas, G. D. & Salek-Ardakani, S. CD8(+) T cell exhaustion in cancer. Front. Immunol. 12, 715234. https://doi.org/10.3389/fimmu.2021.715234 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Thommen, D. S. & Schumacher, T. N. T cell dysfunction in cancer. Cancer Cell 33, 547–562. https://doi.org/10.1016/j.ccell.2018.03.012 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Buller, C. W., Mathew, P. A. & Mathew, S. O. Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer. Cancers https://doi.org/10.3390/cancers12071755 (2020).Article
PubMed
PubMed Central
Google Scholar
Takeuchi, A. et al. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage. J. Exp. Med. 213, 123–138. https://doi.org/10.1084/jem.20150519 (2016).Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou, X. et al. A pan-cancer analysis of CD161, a potential new immune checkpoint. Front. Immunol. 12, 688215. https://doi.org/10.3389/fimmu.2021.688215 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Li, R. et al. Effects of local anesthetics on breast cancer cell viability and migration. BMC Cancer 18, 666 (2018).Article
PubMed
PubMed Central
Google Scholar
Ou, L. et al. 1,3,6-Trigalloylglucose: A novel potent anti-helicobacter pylori adhesion agent derived from aqueous extracts of Terminalia chebula Retz. Molecules (Basel, Switzerland) 29, 1161 (2024).Article
CAS
PubMed
Google Scholar
Ou, L. et al. Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway. J. Ethnopharmacol. 320, 117428. https://doi.org/10.1016/j.jep.2023.117428 (2024).Article
CAS
PubMed
Google Scholar
Peng, C. et al. Syzygium aromaticum enhances innate immunity by triggering macrophage M1 polarization and alleviates Helicobacter pylori-induced inflammation. J. Funct. Foods 107, 105626 (2023).Article
CAS
Google Scholar
Hengrui, L. An example of toxic medicine used in Traditional Chinese Medicine for cancer treatment. J. Tradit. Chin. Med. 43, 209–210 (2023).PubMed
Google Scholar
Liu, H. et al. Exploring the mechanism underlying hyperuricemia using comprehensive research on multi-omics. Sci. Rep. 13, 7161. https://doi.org/10.1038/s41598-023-34426-y (2023).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Berkel, C. & Cacan, E. Half of most frequently mutated genes in breast cancer are expressed differentially between premenopausal and postmenopausal breast cancer patients. Cancer Genet. 286–287, 11–17. https://doi.org/10.1016/j.cancergen.2024.06.001 (2024).Article
CAS
PubMed
Google Scholar
Glaviano, A. et al. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment. Drug Resist. Updat. 76, 101103. https://doi.org/10.1016/j.drup.2024.101103 (2024).Article
CAS
PubMed
Google Scholar
Mundt, E. et al. Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants. Cancer Genet. 278–279, 84–90. https://doi.org/10.1016/j.cancergen.2023.10.002 (2023).Article
CAS
PubMed
Google Scholar
Ward, A. et al. Clinical management of TP53 mosaic variants found on germline genetic testing. Cancer Genet. 284–285, 43–47. https://doi.org/10.1016/j.cancergen.2024.04.002 (2024).Article
CAS
PubMed
Google Scholar
Gonzalez, T., Nie, Q., Chaudhary, L. N., Basel, D. & Reddi, H. V. Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature. Cancer Genet. 282–283, 1–8. https://doi.org/10.1016/j.cancergen.2023.12.003 (2024).Article
CAS
PubMed
Google Scholar